Bharat Biotech Gets DCGI Approval For Phase III Trials Of Intranasal COVID-19 Vaccine As Booster Dose
On the 28th of January, Friday, the Drug Controller General of India (DGCI) approved Phase III trials of Intranasal COVID-19 vaccine. It is to be noted, the Hyderabad based Bharat…